Navigation Links
Prescription in Medical Technology

June 2009 Mayo Clinic Women's HealthSource Highlights Summer Skin Problems, Low Vision and Pilates

... eyes or genitals, a doctor's care is advised. prescription medications, such as an oral corticosteroid, may ... causes and the supplementary tools available when prescription eyeglasses, contact lenses, medicine or surgery ... Magnifying eyeglasses. They are stronger than prescription eyeglasses. The lens may be included with the ...

Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets

... +1-212-468-3194 * Based on total prescription share data. This information is an estimate ... of information under license from IMS National prescription Data for the 12 month period ending December ... and republication. ** IMS national prescription data from 1992-July 2006. (1) Asacol HD ...

Innovative Psoriasis Treatment PSORENT(R) Announces Healthcare Cost Savings Potential Consistent with President Obama's Announcement on Healthcare Reform

... with large pharmaceutical companies to cut prescription costs for the elderly," says Mark D. Steele, ... that has outperformed the leading non-steroidal prescription topical in treating the redness and scaling of ... is significantly less expensive than most prescription drugs for psoriasis, and performs as well or ...

HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens

... steps are taken to help people take their prescription drugs properly. Commonly referred to as ... the end result of Americans not taking their prescription drugs properly is a well-documented phenomenon ... several key reasons why people don't take their prescription drugs properly," notes HCPC Executive Director ...

New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients

... Safety Information SIMPONI(TM) is a prescription medicine. SIMPONI(TM) can lower your ability to ... are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch , ... its research-and-development platform to human prescription and consumer products as well as to animal health ...

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis

... Safety Information SIMPONI(TM) is a prescription medicine. SIMPONI(TM) can lower your ability to ... are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwa t ... its research-and-development platform to human prescription and consumer products as well as to animal health ...

Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily

... groups(10). About ADCIRCA ADCIRCA is a prescription medicine used to treat PAH, a life-threatening ... for CIALIS (tadalafil) CIALIS is available by prescription only and is not for everyone. Men should discuss ... injury. In rare instances, men taking prescription ED tablets (including CIALIS) reported a sudden ...

Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week

... patients were defined as those who refilled their prescription within a period of up to twice the duration of the prescription that preceded the refill. Lialda is an ... the persistency of UC patients who filled a prescription for the aforementioned 5-ASAs between March and ...

Strativa Pharmaceuticals Provides Product Pipeline Update

... prescriptions in 2008. Ondansetron was the prescription leader in the category, accounting for 95% of ... is committed to developing and marketing novel prescription drugs. Its initial focus is on supportive care ... drug products, and a development pipeline of prescription formulations based on PharmFilm(R) technology. ...

American Lung Association Study to be Published in the 'New England Journal of Medicine' Finds Prescription Heartburn Medication Does Not Control Asthma Symptoms as Previously Thought

... or other asthma symptoms. These results show that prescription acid controllers were no more effective than ... evaluation to date of the efficacy of prescription heartburn medication to control respiratory ... are spending as much as $10 million dollars on prescription heartburn medication believing it will help ...

New Study Suggests Rx Estrogen Delivery Through the Skin May Show Safety Benefits as Opposed to Oral Delivery

... delivery of estrogen therapy available by prescription "seems not to alter" the risk of venous ... of the North American Menopause Society. prescription transdermal estrogen therapy is bioidentical to ... Transdermal estrogen therapies available by prescription offer effective, low-dose estrogen for the ...

American Oriental Bioengineering to Initiate a Phase One Clinical Trial in the United States of AOBO-001 Oral Capsule

... and commercialization of a broad range of prescription and over the counter ("OTC") products, announced ... in the U.S. Given the history and usage of this prescription UI treatment, we are optimistic that we can ... and commercialization of a broad range of prescription and over the counter products. Statements ...

Thomson Reuters Study Finds Sharp Increase in Use of Sleep Medications by Young Adults

... ANN ARBOR, Mich., Jan. 16 /PRNewswire/ -- Use of prescription sleep aids nearly tripled among 18- to ... causing larger numbers of young adults to turn to prescription sleep aids, and to depend on them for longer ... found a 50-percent increase in the use of prescription sleep aids among all adults under age 45 from ...

FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes

... . IMPORTANT SAFETY INFORMATION FOR LANTUS(R) prescription Lantus(R) is for adults with type 2 diabetes or ... * Based on TRx data from IMS Health, National prescription AuditTM (Next Generation prescription Methodology). Time period: May 2003 to ....

New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients

... Munich, Germany on Sunday, August 31, 2008. The prescription omega-3 utilized in this study is made by ... new insights into the potential benefits of prescription omega-3s in heart failure and should not ... for cardiovascular reasons. Treatment with prescription omega-3 acid ethyl esters resulted in a ...

MonoSol Rx Completes Thin Film Escitalopram Oxalate Pilot Product Development

... patient benefits over other currently marketed prescription drug products and will help ensure that patients ... our capacity to develop and manufacture thin film prescription products at commercial scale for a ... OTC drug products, and a pipeline of prescription formulations utilizing its PharmFilm(R) ...

HealthMedia and Aetna to Study Online Insomnia and Depression Interventions

... will identify members who are chronic users of prescription sleep medications. For the depression program, ... The insomnia program will study the impact on prescription medication utilization. According to one study, ... of the decade. Golinkoff confirmed that Aetna's prescription insomnia medication costs have been ...

New Data Show High Frequency of Medical Claims for Gastrointestinal Events by Patients on Antiplatelet Therapy

... Plavix(R), is among the world's largest-selling prescription medicines and is prescribed to prevent ... patients in the 12 months following their first prescription for clopidogrel. "This study provides important ... developer of innovative, fixed-dose combination prescription medicines serving unmet medical needs that drive ...

Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R)

... . IMPORTANT SAFETY INFORMATION FOR LANTUS(R) prescription Lantus(R) is for adults with type 2 diabetes or ... * Based on TRx data from IMS Health, National prescription Audit(TM) (Next Generation prescription Methodology). Time period from May 2003 ...

More Than 1.5 Million Americans Sickened, Injured or Killed by Medication Errors Each Year; Seniors Most at Risk

... dangers (the use of multiple prescription drugs simultaneously) and noncompliance (failure ... are attributed to adverse reactions to prescription drugs -- The average elderly person takes 4-6 ... a patient's entire drug profile, check that prescription combinations are safe and make recommendations ...

Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction

... in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction, today ... under our sponsorship. There are currently no prescription drugs approved for the treatment of this ... on the development and commercialization of prescription drugs for the treatment of addiction. The Company ...

Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis

... developed and marketed a wide range of prescription products since the 1980s, including Actonel(R), ... For more information on P&GP and its prescription product portfolio, please visit ... information under license from IMS National prescription Data for the 12-month period ending February ...

Younger Adults Increasingly Treated for Heart Disease-related Conditions

... by Medco Health Solutions, Inc. (NYSE: MHS ), prescription drug use by younger adults for heart disease- ... and 2006, the number of 20-44 year olds taking prescription medications to treat high cholesterol increased ... integrated databases that provide real- time prescription medication history, and medical diagnoses ...

Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930

... biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and Mercury Therapeutics, Inc. ... biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs. The group in-licenses promising ...

NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study

... in the clinical development program. The NDA for Qutenza in PHN has a prescription Drug User Fee Act (PDUFA) date of August 16, 2009. In Study ... which was accepted for filing by the FDA in December 2008 and was given a prescription Drug User Fee Act (PDUFA) date of August 16, 2009. NeurogesX' ...

Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl)

... combination (FDC) of alogliptin and ACTOS((R)) (pioglitazone HCl). The new prescription Drug User Fee Act (PDUFA) date for the FDC is September 4, 2009. ... About ACTOS ((R)) (pioglitazone HCl) ACTOS is a prescription medication used with diet and exercise to improve blood sugar (glucose) ...

Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma

... TWISTHALER. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch , or call 1-800-FDA-1088 ... initiated. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch , or call 1-800-FDA-1088. ...

Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations

... biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today announced that the Swiss ... biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs. It develops its products for global ...

Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations

... biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today announced that the Swiss ... biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs. It develops its products for global ...

FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent

... About Tekturna and Tekturna HCT TEKTURNA and TEKTURNA HCT are prescription medications for adults used to treat high blood pressure. TEKTURNA and ... researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those ...

Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV

... world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. ... 12: 385-390. 2 Atazanavir sulfate is a Bristol-Myers Squibb Company prescription medicine. Please see the atazanavir product insert for information on ...

Dry Mouth Linked to Prescription and Over the Counter Drugs

... be at diagnosing and treating patients." There are more than 400 prescription and non-prescription drugs associated with xerostomia, according to ... Out of the nearly 500 general dentists who responded, 89 percent believe prescription medications are the primary contributor to dry mouth. Aging, dehydration ...

Mayo Clinic Proceedings: A Comprehensive Review of Addiction to Prescription Painkillers Among Patients and Physicians

... timely. As the immense challenges, including potential tragedies, of prescription chemical addiction and abuse are being discussed, these articles offer crucial overview, direction and optimism. Addiction to and abuse of prescription opioid drugs are prevalent, and they exact an immense toll on patients, ...

King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use

... bioavailability of the opioid. Although the combination of EtOH and prescription opioids is frequently cited as having increased impairing effects, very ... through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products and technologies that complement the Company's ...

Salvacyl(R), Developed by Debiopharm, is Launched in two European Countries

... biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announced that Salvacyl(R) (also ... biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs. It develops its products for global ...

Research: Popular Diabetes Medications Associated with Increase in Bone Fractures

... provided a list of available medications available in the category and a prescription form pre-populated with the patient's information. Twenty-one percent of ... agencies of all sizes, and for individuals served by Medicare Part D prescription Drug Plans. Through its unique Medco Therapeutic Resource Centers (R) ...

New Study Showed Lantus(R) Plus One, Two or Three Shots of Apidra(R) Lowered Patients' Blood Sugar

... * Based on TRx data from IMS Health, National prescription AuditTM (Next Generation prescription Methodology). Time period: May 2003 to February 2009. (C) 2009 ...

Large, Long-Term Study Shows Avandia Has No Increased Overall Cardiovascular Risk Compared to Other Commonly Used Diabetes Medicines

... safety information for Avandia (R) (rosiglitazone maleate) prescription AVANDIA, along with diet and exercise, helps improve blood sugar control ... . You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch , or call ...

NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia

... Company's new drug application (NDA) for Qutenza in PHN and has assigned a prescription Drug User Fee Act (PDUFA) date of August 16, 2009. Qutenza, if approved by ... which was accepted for filing by the FDA in December 2008 and was given a prescription Drug User Fee Act (PDUFA) date of August 16, 2009. NeurogesX' second ...

Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients

... in children. Tell your doctor if you are taking other medicines, including prescription and non-prescription medicines, vitamins, or herbal supplements. ... 1-800-545-5979. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch , or call 1-800-FDA-1088. ...
Other Contents
(Date:7/11/2014)... 2014, Shenzhen, China Researchers from Salk Institute for ... first time evaluated the safety and reliability of ... developed a new method, TALEN-HDAdV, which could significantly ... cell (hiPSC). This study published online in ... foundation for stem cell-based gene therapy. , The ...
(Date:7/11/2014)... 11, 2014 Researchers have pioneered a revolutionary ... new technology, called Virtual Finger, allows scientists to ... neurons and synapses using the flat surface of ... 3D imaging studies orders of magnitude more efficient, ... level across many areas of experimental biology. The ...
(Date:7/11/2014)... that under the normal circumstances, astrocytes participate ... neuronal environment, and exhibit therapeutic and repairing ... Previous studies have found that nerve cells ... induction have reduced viability, which produces influences ... Yuan, Kailuan General Hospital, Hebei United University, ...
Breaking Biology News(10 mins):A new genome editing method brings the possibility of gene therapies closer to reality 2Virtual finger enables scientists to navigate and analyze complex 3D images 2
(Date:7/13/2014)... 2014 Athletes with a certain genetic ... concussions, according to research presented today at the American ... Meeting. The research marks the first of its kind ... known physical events that occur after a head injury. ... allele in the (GT)n genotype were four times more ...
(Date:7/13/2014)... Rico (PRWEB) July 13, 2014 ... of Famer, Chris Mullin, will be the featured guest ... July 26th in Puerto Rico. Attendees will learn ... will participate in two exhibition basketball games and perform ... ultimate supplier of health- and energy-boosting supplements , ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 Epidemiologists forecast ... in the 6MM, from 8,062 diagnosed incident cases in ... an Annual Growth Rate (AGR) of 4.35%, during the ... highest number of diagnosed incident cases of aGVHD in ... will have the lowest number of diagnosed incident cases ...
(Date:7/13/2014)... According to the Kidney Disease Solution book ... step guide on what to do to eliminate the root ... writes in its review that readers can easily learn what ... their kidney health. Vkool also informs in its Kidney Disease ... damaged kidney functions naturally. The book consists of a collection ...
(Date:7/13/2014)... Beverly Hills, California (PRWEB) July 13, 2014 ... Champion Danny Musico has formed a promotional partnership with ... revolutionary plant based Omega-3 EPA supplement . The ... Musico is a celebrity fitness trainer , actor, ... As Hollywood’s go-to trainer for A-List celebrities, he has ...
Breaking Medicine News(10 mins):Health News:Genetic Factors May Be Responsible for Slowing Concussion Recovery in Athletes 2Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 2Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 3Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 4Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 2Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 3Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 4Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 2Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 3Health News:Celebrity Fitness Expert Supports Revolutionary New Health Supplement 2
Other TagsOther Tags